Longitudinal change in FEV1 in adults with cystic fibrosis treated with elexacaftor–tezacaftor–ivacaftor in France: a prospective observational study. // The Lancet Respiratory Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S221326002600281X?dgcid=rss_sd_all
Longitudinal change in FEV1 in adults with cystic fibrosis treated with elexacaftor–tezacaftor–ivacaftor in France: a prospective observational study. The Lancet Respiratory Medicine. https://www.sciencedirect.com/science/article/pii/S221326002600281X?dgcid=rss_sd_all
“Longitudinal change in FEV1 in adults with cystic fibrosis treated with elexacaftor–tezacaftor–ivacaftor in France: a prospective observational study.” The Lancet Respiratory Medicine.
@article{article32436,
title = {Longitudinal change in FEV1 in adults with cystic fibrosis treated with elexacaftor–tezacaftor–ivacaftor in France: a prospective observational study},
journal = {The Lancet Respiratory Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S221326002600281X?dgcid=rss_sd_all}
}